Jessie L Kunz, CNM MSN | |
8301 Golden Valley Rd, Suite 100, Golden Valley, MN 55427-4435 | |
(763) 520-2211 | |
(763) 520-2222 |
Full Name | Jessie L Kunz |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 8301 Golden Valley Rd, Golden Valley, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1891004644 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | CNM0121 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jessie L Kunz, CNM MSN 8301 Golden Valley Rd, Suite 100, Golden Valley, MN 55427-4435 Ph: (763) 520-2211 | Jessie L Kunz, CNM MSN 8301 Golden Valley Rd, Suite 100, Golden Valley, MN 55427-4435 Ph: (763) 520-2211 |
News Archive
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that the company will be giving poster and oral presentations on results from its Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome (IBS) at Digestive Disease Week (DDW) 2010 in New Orleans, Louisiana.
A Food and Drug Administration investigation last year found that Masimo Corp. did not adequately look into reports of problems with its devices, ProPublica reports, even though the company owner, Joe Kiani, has created a foundation dedicated to eliminating medical mistakes. In addition, the Boston Globe examines how medical technology companies are looking for new strategies to boost sales.
Impax Laboratories, Inc. today confirms that Alza Corporation has filed suit for patent infringement against Impax in the United States District Court for the District of Delaware in connection with Concerta® (methylphenidate hydrochloride) extended-release 54 mg tablets.
Immunogenetics experts at The Children's Hospital of Philadelphia (CHOP) have developed a unique laboratory test to characterize the genes that encode HLA molecules. The test relies on faster, more comprehensive gene sequencing technology to type human leukocyte antigens (HLAs)-complex, highly variable proteins on cell surfaces that are essential to immune function.
› Verified 5 days ago